Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial - Skljarevski, Vladimir; Matharu, Manjit; Millen, Brian A; Ossipov, Michael H; Kim, Byung-Kun; Yang, Jyun Yan (Cephalalgia, 2018)
Keywords: LY2951742; Episodic migraine; MIDAS; galcanezumab; MSQ; headache; humanized monoclonal antibody; CGRP